Search:
Filter:
Sort:
On August 7, the Partnership for Safe Medicines and ADAP Advocacy Association filed a complaint asking the New York State Board of Pharmacy to take regulatory action against a pharmacy that allegedly sold counterfeit HIV medicine to a Queens, New York patient.
Read More
Handout: The fake pill trade hasn’t gone away It’s been 10 years since deadly counterfeit prescription pills began killing Americans. News about fake pill deaths has become commonplace and advocates have made progress to protect lives, but many people still don’t know about this threat or the pill presses that make it possible. Share this PDF to help bring them…
Read More
PSM and ADAP Advocacy Association filed an official complaint with the State of New York regarding allegations that City Plus Care Pharmacy Inc. dispensed counterfeit HIV medication to a patient in Queens, New York.
Read More
Statistics in the agency’s Report on the State of Pharmaceutical Quality show that active pharmaceutical ingredient (API) sites that solely supply compounding pharmacies are disproportionately high risk.
Read More
Used an alternative funding program? Tell us your story The Partnership for Safe Medicines is researching alternative funding programs. If you are a patient or an administrator, we’d like to confidentially interview you to understand how you have encountered these programs, how they work, and what your experience was. If you’re ready to interview, or at least speak to us…
Read More
The proposed updates aim to help address safety concerns created by pharmacies reselling compounded sterile drugs purchased from outsourcing facilities.
Read More
The Pennsylvania Attorney General filed charges against a pharmacy owner and the Ohio Board of Pharmacy revoked licenses to protect patients.
Read More
The newest Fishy Freight report continued to find suspect API shipped into the U.S. while a report from the United Nations’ Office of Drug Crime highlighted the dangers of contaminated and counterfeit medicines made with diethylene glycol and ethylene glycol.
Read More
What if your tirzepatide shipment came from a Brazilian beauty clinic? Or a vial of semaglutide was manufactured, supposedly, at a Costco in Toronto? In April and May 2025, dozens of shipments of semaglutide, tirzepatide, apixaban, and antibiotics entered the U.S. from facilities that aren’t in the FDA’s drug manufacturing database. These aren’t low-volume personal-use shipments; we looked at freight-scale…
Read More
We’ve published the final document of best practices for online pharmacy-to-pharmacy marketplaces.
Read More